DK0416984T3 - Middel til diagnose af demyeliniserende neuropatier, især dissemineret sklerose - Google Patents

Middel til diagnose af demyeliniserende neuropatier, især dissemineret sklerose

Info

Publication number
DK0416984T3
DK0416984T3 DK90402399.1T DK90402399T DK0416984T3 DK 0416984 T3 DK0416984 T3 DK 0416984T3 DK 90402399 T DK90402399 T DK 90402399T DK 0416984 T3 DK0416984 T3 DK 0416984T3
Authority
DK
Denmark
Prior art keywords
diagnosis
agent
demyelinating neuropathies
disseminated sclerosis
lectins
Prior art date
Application number
DK90402399.1T
Other languages
English (en)
Inventor
Jean-Pierre Zanetta
Jean-Marie Warter
Sabine Kuchler
Guy Vincendon
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of DK0416984T3 publication Critical patent/DK0416984T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/828—Protein A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Valve Device For Special Equipments (AREA)
  • Air Bags (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Steering-Linkage Mechanisms And Four-Wheel Steering (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Ignition Installations For Internal Combustion Engines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
DK90402399.1T 1989-09-06 1990-08-30 Middel til diagnose af demyeliniserende neuropatier, især dissemineret sklerose DK0416984T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8911667A FR2651581B1 (fr) 1989-09-06 1989-09-06 Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques.

Publications (1)

Publication Number Publication Date
DK0416984T3 true DK0416984T3 (da) 1993-08-16

Family

ID=9385190

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90402399.1T DK0416984T3 (da) 1989-09-06 1990-08-30 Middel til diagnose af demyeliniserende neuropatier, især dissemineret sklerose

Country Status (14)

Country Link
US (1) US5225352A (da)
EP (1) EP0416984B1 (da)
JP (1) JP3032290B2 (da)
AT (1) ATE90791T1 (da)
AU (1) AU648516B2 (da)
CA (1) CA2024731A1 (da)
DE (1) DE69001972T2 (da)
DK (1) DK0416984T3 (da)
ES (1) ES2057476T3 (da)
FI (1) FI921009A0 (da)
FR (1) FR2651581B1 (da)
IE (1) IE64042B1 (da)
NO (1) NO920852L (da)
WO (1) WO1991003737A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679034A1 (fr) * 1991-07-10 1993-01-15 Centre Nat Rech Scient Determination de la malignite des cellules de tumeurs humaines ou animales, au moyen de lectines endogenes.
FR2689521B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture.
FR2689520B1 (fr) 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
AU704440B2 (en) * 1994-02-04 1999-04-22 Bio Merieux MSRV1 virus and MSRV2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
FR2716198B1 (fr) * 1994-02-15 1996-04-19 Bio Merieux Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
FR2737500B1 (fr) * 1995-08-03 1997-08-29 Bio Merieux Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques
EP0942987B1 (en) * 1996-11-26 2009-08-19 Bio Merieux Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
JPH11143616A (ja) 1997-11-10 1999-05-28 Sega Enterp Ltd 文字通信装置
WO2000007602A1 (en) * 1998-08-06 2000-02-17 The Johns Hopkins University School Of Medicine Compounds for altering cell surface sialic acids and methods of use therefor
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
US6899726B2 (en) 2000-10-05 2005-05-31 Seacoast Technologies, Inc. Expandable device for thermal therapy including spiral element
US7858602B2 (en) * 2000-10-16 2010-12-28 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
WO2004034031A2 (en) * 2002-10-11 2004-04-22 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis
US6947870B2 (en) * 2003-08-18 2005-09-20 Baker Hughes Incorporated Neural network model for electric submersible pump system
FI20155280A7 (fi) 2015-04-15 2016-10-16 Medicortex Finland Oy Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311686A (en) * 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
FR2618439B1 (fr) * 1987-07-21 1990-05-25 Strosberg Arthur Sequences d'amino-acides reproduisant au moins en partie la sequence des lectines animales et humaines, leurs procedes d'obtention, leurs applications diagnostiques et therapeutiques
ES2096557T3 (es) * 1988-04-14 1997-03-16 Incyte Pharma Inc Lectinas 14-beta-gal de mamiferos.

Also Published As

Publication number Publication date
JPH05500858A (ja) 1993-02-18
FI921009A7 (fi) 1992-03-06
ATE90791T1 (de) 1993-07-15
FR2651581A1 (fr) 1991-03-08
NO920852D0 (no) 1992-03-04
ES2057476T3 (es) 1994-10-16
WO1991003737A1 (fr) 1991-03-21
DE69001972T2 (de) 1993-09-23
JP3032290B2 (ja) 2000-04-10
FR2651581B1 (fr) 1994-05-13
AU648516B2 (en) 1994-04-28
IE64042B1 (en) 1995-06-28
NO920852L (no) 1992-03-04
US5225352A (en) 1993-07-06
DE69001972D1 (de) 1993-07-22
FI921009A0 (fi) 1992-03-06
AU6421490A (en) 1991-04-08
CA2024731A1 (fr) 1991-03-07
EP0416984A1 (fr) 1991-03-13
EP0416984B1 (fr) 1993-06-16
IE903190A1 (en) 1991-03-13

Similar Documents

Publication Publication Date Title
AU648516B2 (en) Means for diagnosing demyelinating neuropathies, in particular multiple sclerosis
NO874971L (no) Forbedret metallholdig diagnostisk middel.
DE69129302D1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
DE58909388D1 (de) Verfahren zur Bestimmung von Suchpositionen zur Bewegungsschätzung.
AR211200A1 (es) Una mejorada composicion que contiene proteina de suero batible.
FR2602145B3 (fr) Nouvel agent de contraste pour les images de rmn, particulierement utile aux applications medicales de la rmn
SE8104016L (sv) Framstellning av limulus-lysat
ES520985A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidrodibenzo (b,e)-tiepin-11-n-alcohilnorescopin-eteres cuaternarios.
NO904291D0 (no) Fremgangsmaate for fremstilling av radiomerkede antikoagulerende peptider.
DE59001418D1 (de) Antikoagulanz enthaltendes mittel.
FR2652893B1 (fr) Appareil de lecture de contour, notamment pour monture de lunettes.
SE8009157L (sv) Sett att framstellning hogrenade koncentrat av protrombinkomplex, de erhallna koncentraten och framstellning derav
SE8403630L (sv) Humana proteiner
ES2072423T3 (es) Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre.
TR199801027T2 (xx) Epitelyom te�his ve tedavisi i�in y�ntem.
NO904292D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
DE69015155D1 (de) Strahlteiler für farbabbildungsvorrichtung.
LU90380I2 (fr) Tetravac
DK100384A (da) Objektplade til afproevning af okkult blod
DE69014253D1 (de) Scheinwerfereinrichtung für Fahrzeuge.
ES2074591T3 (es) Expresion de polipeptidos de vih 1 y 2 y su utilizacion.
DE3570677D1 (en) Acino-foetal differentiation proteins associated with cancer of the pancreas, antiserum and monoclonal antibodies against these proteins and processes for their preparation
NO930234L (no) Antikoagulerende midler
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
DE59003769D1 (de) Scheinwerfer für Fahrzeuge.